MiRXES is a spin-off from the Bioprocessing Technology Institute of the Agency of Science Technology And Research (A*STAR) and is supported by Exploit Technologies and the National University of Singapore. MiRXES collaborates extensively with academic, clinical and industrial partners locally and globally in advancing the science and business of miRNA.
Harnessing the power of miRNA to transform cancer management :
MiRXES is looking to revolutionise cancer detection methods by offering blood tests in place of current diagnostic methods to detect early stage cancer. MiRXES develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions.